• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine

Patent holdings for IPC class A61K 31/4375

Total number of patents in this class: 3538

10-year publication summary

248
223
296
268
271
298
302
301
339
22
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Deciphera Pharmaceuticals, LLC
201
66
Novartis AG
11254
61
F. Hoffmann-La Roche AG
7942
45
Incyte Corporation
963
43
Immunomedics, Inc.
279
42
Bristol-myers Squibb Company
4863
41
Bayer Pharma AG
1085
41
Merck Patent GmbH
5842
39
Merck Sharp & Dohme LLC
3751
35
Boehringer Ingelheim International GmbH
4754
34
Takeda Pharmaceutical Company Limited
2943
27
Hoffmann-La Roche Inc.
3267
26
Pfizer Inc.
3368
25
Bayer AG
3209
25
Shenzhen HighTide Biopharmaceutical, Ltd.
52
25
Merck Sharp & Dohme Corp.
2219
24
Gilead Sciences, Inc.
1951
24
Pliant Therapeutics, Inc.
61
22
Genentech, Inc.
3869
21
Mayo Foundation for Medical Education and Research
3115
21
Other owners 2851